Regenxbio says Duchenne gene therapy improved motor skills in five patients
Regenxbio announced the latest functional outcomes of five children with Duchenne muscular dystrophy who received its gene therapy.
The muscle disease …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
